Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

Brazil

Victory Square’s (VST.C) portfolio companies IV Hydreight and Victory Square Health (VSH) will be combining resources to create and expand telehealth product offerings in Brazil. “My team members and…
Heritage Cannabis (CANN.C) has been granted an export license by Health Canada. The license will permit the Company to export cannabis products to Brazil marking the first-ever license granting…
Heritage Cannabis Holdings (CANN.C) subsidiary, CannaCure, got in on a binding letter of intent for a three year extraction and finished product supply deal for pharmaceutical products with Brazil-based…
Victory Square Technologies (VST.C) entered into a new sales and distribution contract with a Brazil based medical production and supply company today, according to a press release. The contract…
Victory Square Health/Safetest, a subsidiary of Victory Square Technologies (VST.C), has gotten the nod from the Brazilian Ministry of Agriculture, Livestock and Food Supply (MAPA) for marketing, selling and…
Marijuana Company of America (MCOA.OTCQB) launched two subsidiaries that they hope will help them expand their hempsmart product line into the South American markets, and specifically Brazil and Uruguay,…
Victory Square Health, a subsidiary of Victory Square Technologies (VST.C), signed into an agreement to purchase a certified laboratory and production facility in Minas Gerais, Brazil yesterday. The laboratory…
Whatever your feelings about Brazillian President Jair Bolsonaro, his plan to increase total infrastructure investment through partnerships or privatization seems to be bearing fruit. The Brazil government’s plan to…
The financial crisis of 2007 wiped trillions off our global financial ledger. National economies reeled in the wake of banking’s biggest boo-boo since Reagan’s deregulation of the American Savings…
There is a dearth of cannabis-related clinical studies, and Khiron Life Sciences (KHRN.V) is putting in the work to change that. Today, the company has begun its pre-clinical medical cannabis studies…